How much does platinib cost for patients with lung cancer?

Pralsetinib is a targeted therapy for RET gene fusion-positive lung cancer and is suitable for patients with specific types of lung cancer such as non-small cell lung cancer. As a new type of targeted drug, it has shown positive efficacy in controlling tumor progression and prolonging progression-free survival. Platinib was developed by Blueprint Medicines and is an original drug. It has been approved for marketing in many countries and regions, including China.

In the domestic market, the original drug Platinib has been officially launched, but it has not yet been included in the national medical insurance directory, which means that patients need to pay for the drug entirely at their own expense. Common specifications include 100mg 60 capsules and 100mg 120 capsules, of which 60 capsules is around 20,000 yuan, while the price of 120 capsules is even higher. The retail price in some cities is even as high as 60,000 yuan. This economic burden cannot be underestimated for lung cancer patients who take long-term medication.

Compared with domestic prices, the price of platinib’s original drug in overseas markets fluctuates more obviously. 60The price range of capsules is roughly between 40,000 yuan to more than 100,000 yuan. The specific price is affected by factors such as region, channel, taxes and fees. In European and American countries, original drug prices are generally high, so many patients will look for more cost-effective alternatives through international drug purchasing or formal channels.

In order to alleviate the financial pressure on patients, some overseas pharmaceutical companies have also developed generic versions of platinib. At present, the generic drug of Platinib produced in Laos has attracted widespread attention. Its ingredients are basically the same as the original drug and its efficacy is also similar. 120The price of a box of generic drugs is about more than 3,000 yuan, which is significantly lower than the price of the original drugs, providing a more affordable treatment option for the majority of patients. However, before choosing medication, it is still recommended that patients weigh the efficacy and cost under the guidance of a doctor to ensure the safety and effectiveness of the treatment.

Reference materials:https://gavreto.com/